Delivery Order SPE2DR25D2009-SPE2DR26FJ4B0
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $56K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,967.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $27,363.70, with completion scheduled for May 8, 2025. The order represents a firm fixed-price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be...
- The Defense Logistics Agency awarded a $4,212.77 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 11, 2025. This competitive award, issued on a firm fixed price basis, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical distributor,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with a ceiling value of $3,265.08. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,048.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $11,367.80 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on December 2, 2025, with completion expected by December 3, 2025. This non-competitive delivery order represents a firm fixed price transaction issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This competitive award, valued at $7,167.84 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The ultimate completion date is set for September 23, 2025....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,359.77 by the Defense Logistics Agency for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors (0.5 mL). The contract was competitively awarded with firm fixed pricing and carries an ultimate completion date of December 9, 2025. The award was made without a set-aside designation, and performance is based in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate headquarters is located. This delivery order represents...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,637.01 on December 1, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors valued at $3,841.41 with a firm fixed price structure. This non-competitive delivery order, issued on December 8, 2025, is scheduled for completion by December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...